Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer
Clinical trial NCT05479240 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05479240
- Sponsor
- Fujian Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-06-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.